Yan Pan
Yangtze University(CN)First Affiliated Hospital of Henan University(CN)Wuxi People's Hospital(CN)Hangzhou Medical College(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Kawasaki Disease and Coronary Complications, Cancer-related molecular mechanisms research, Coronary Artery Anomalies, RNA modifications and cancer, MicroRNA in disease regulation
Most-Cited Works
- → MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2(2010)222 cited
- → Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway(2016)127 cited
- → Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non‐small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production(2011)84 cited
- → Targeted Disruption of the ATP2A1 Gene Encoding the Sarco(endo)plasmic Reticulum Ca2+ ATPase Isoform 1 (SERCA1) Impairs Diaphragm Function and Is Lethal in Neonatal Mice(2003)80 cited
- → BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation(2020)70 cited
- → MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer(2015)52 cited